Cellanome Stock

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

Sign up today and learn more about Cellanome Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cellanome Stock

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform. The company's platform specializes in molecular biology, biochemistry, microfluidics, integrated sensors, and genome sequencing, enabling scientists to create novel solutions to challenging biological issues. Cellanome was established in 2020 by Mostafa Ronaghi in Redwood City, California.

Funding History

October 2021$2.0M
December 2021$21.0M
August 2022$40.7M

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo